{
    "id": 25145,
    "fullName": "EGFR I941R",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR I941R lies within the protein kinase domain of the Egfr protein (UniProt.org). I941R confers a loss of function on the Egfr protein as indicated by disruption of dimerization in culture (PMID: 24063894, PMID: 24894453).",
            "references": [
                {
                    "id": 1846,
                    "pubMedId": 24063894,
                    "title": "Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24063894"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 1125,
                    "pubMedId": 24894453,
                    "title": "Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24894453"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "I941R",
    "createDate": "08/04/2016",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": {
        "id": 135707,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55198837_55198838delTCinsGG",
        "cDna": "c.2822_2823delTCinsGG",
        "protein": "p.I941R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7589,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells over expressing EGFR that harbors concomitant L858R, T790M and I941R mutations demonstrated increased sensitivity to EAI045 induced growth inhibition in culture (PMID: 27251290).",
            "molecularProfile": {
                "id": 25912,
                "profileName": "EGFR T790M EGFR L858R EGFR I941R"
            },
            "therapy": {
                "id": 4520,
                "therapyName": "EAI045",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6436,
                    "pubMedId": 27251290,
                    "title": "Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27251290"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18679,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, JBJ-04-125-02 02 inhibited Egfr activation in a transformed mouse cell line expressing EGFR L858R and T790M in culture (PMID: 31092401).",
            "molecularProfile": {
                "id": 25912,
                "profileName": "EGFR T790M EGFR L858R EGFR I941R"
            },
            "therapy": {
                "id": 8684,
                "therapyName": "JBJ-04-125-02",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16071,
                    "pubMedId": 31092401,
                    "title": "Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31092401"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25910,
            "profileName": "EGFR I941R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 25912,
            "profileName": "EGFR T790M EGFR L858R EGFR I941R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135707,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55198837_55198838delTCinsGG",
            "cDna": "c.2822_2823delTCinsGG",
            "protein": "p.I941R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}